Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, USA.
Cancer Med. 2019 Nov;8(16):6809-6831. doi: 10.1002/cam4.2577. Epub 2019 Sep 30.
The number of patients who develop metastatic brain lesions is increasing as the diagnosis and treatment of systemic cancers continues to improve, resulting in longer patient survival. The role of surgery in the management of brain metastasis (BM), particularly multiple and recurrent metastases, remains controversial and continues to evolve. However, with appropriate patient selection, outcomes after surgery are typically favorable. In addition, surgery is the only means to obtain a tissue diagnosis and is the only effective treatment modality to quickly relieve neurological complications or life-threatening symptoms related to significant mass effect, CSF obstruction, and peritumoral edema. As such, a thorough understanding of the role of surgery in patients with metastatic brain lesions, as well as the factors associated with surgical outcomes, is essential for the effective management of this unique and growing patient population.
随着系统性癌症的诊断和治疗不断改善,发生转移性脑病变的患者数量正在增加,导致患者的生存时间延长。手术在脑转移瘤(BM)管理中的作用(尤其是多发性和复发性转移瘤)仍然存在争议,并在不断发展。然而,通过适当的患者选择,手术后的结果通常是有利的。此外,手术是获得组织诊断的唯一手段,也是快速缓解与显著肿块效应、CSF 阻塞和肿瘤周围水肿相关的神经并发症或危及生命症状的唯一有效治疗方式。因此,彻底了解手术在转移性脑病变患者中的作用以及与手术结果相关的因素,对于有效管理这一独特且不断增长的患者群体至关重要。